Search the Newsreel

M&G Stock And Legal And General Shares For Inflation Protection In The UK

Fulgent Genetics Inc (FLGT) Financial Health: Profitability & Balance Sheet Analysis

Fulgent Genetics Inc (FLGT) currently holds a financial score of 6.89, placing it 52nd out of 75 in the Healthcare Providers & Services industry, indicating stable financial health and high operating efficiency. Despite this, its latest quarterly revenue decreased by 3.16% year-over-year to $71.14M, …

Behavioral Patterns of FLGT and Institutional Flows

This article analyzes behavioral patterns and institutional flows for Fulgent Genetics Inc. (NASDAQ: FLGT), suggesting a near-term neutral sentiment that may pause mid- and long-term weakness. It highlights an exceptional 96.0:1 risk-reward setup targeting a 26.9% gain with minimal risk. The report also provides …

Fulgent Genetics Inc (FLGT) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Fulgent Genetics Inc (FLGT), noting its score of 6.80, which ranks 25 out of 75 in the Healthcare Providers & Services industry. The company's beta of 0.93 indicates it tends to underperform in up markets but decline …

Fulgent Genetics Inc expected to post a loss of 46 cents a share - Earnings Preview

Fulgent Genetics Inc (FLGT) is projected to report a loss of 46 cents per share in its upcoming earnings announcement. This preview indicates the anticipated financial performance for the company, suggesting a negative earnings per share.

Fulgent Genetics CSO Gao Hanlin Executes Tax-Related Sale of 1,645 Shares at $19.67 on July 26, 2026

Gao Hanlin, Chief Scientific Officer of Fulgent Genetics, Inc. (NASDAQ: FLGT), sold 1,645 common shares at $19.67 each on July 26, 2026, to cover tax obligations. Following this transaction, Hanlin still directly owns 988,729 common shares in the genomics testing company. The sale was …

Fulgent Genetics Inc (FLGT) Cash Flow

This article provides a detailed quarterly and annual cash flow statement for Fulgent Genetics Inc (FLGT), covering operating, investing, and financing activities. It presents financial data including net income, capital expenditures, and changes in working capital over several years. The report also includes FAQs …

Fulgent Genetics Inc (FLGT) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Fulgent Genetics Inc (FLGT) stock, focusing on its dividend and stock split history. It notes that the company has not distributed any dividends over the past five years. The page displays various financial metrics and stock performance data …

By 2030, the dividends from Legal & General shares could grow to…

Fulgent Genetics Inc (FLGT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Fulgent Genetics Inc (FLGT), categorized by business segments and regional contributions. For specific financial periods, it indicates the revenue proportions from Institutional, Insurance, and Patient segments, as well as from the United States and Foreign regions. …

FLGT|Fulgent Genetics Inc|Price:19.670|Chg%:-0.310

Fulgent Genetics Inc (FLGT) trades at $19.670, showing a -1.55% change. The company has healthy fundamentals and significant growth potential, although its valuation is considered fairly valued within the Healthcare Providers & Services industry. One analyst rates FLGT as "Hold" with a target price …

Fulgent Genetics, Inc. Revenue Breakdown – FWB:7F0

Fulgent Genetics, Inc. (FWB:7F0) generated €274.73 million in revenue last year, with its Laboratory Services segment contributing the most at €274.35 million. The majority of the revenue, €252.49 million, originated from the United States. This financial overview highlights the company's key revenue streams and …

Fulgent Genetics (FLGT) to Release Earnings on Thursday

Fulgent Genetics (FLGT) is scheduled to release its Q2 2026 earnings before market open on Thursday, July 30th, with analysts anticipating a loss of $0.46 per share on revenues of $94.0 million. Wall Street maintains a "Hold" rating for FLGT with a consensus price …

Legal & General vs Investec: which is the best stock for second income?

(FLGT) Movement Within Algorithmic Entry Frameworks

This article analyzes Fulgent Genetics Inc. (NASDAQ: FLGT) using algorithmic frameworks, highlighting mixed sentiment and a mid-channel oscillation pattern. It presents three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for different risk profiles, along with multi-timeframe signal analysis. The report also notes …

FLGT Forecast — Price Target — Prediction for 2027

Fulgent Genetics (FLGT) Stock Faces Mixed Analyst Target Changes After Margin Questions

Have Legal & General shares been a good investment over the last 5 years?

FLGT Q1 2026 Earnings: Significant EPS Miss, Stock Rises on Potential Strategic Moves - EPS Revision Trend

Here’s why Legal & General is still one of the UK’s most popular SIPP buys

Legal & General FTSE 100 Retirement Leaders Supporting UK Pension Planning

Legal & General FTSE 100 Dividend Income Stocks Linked to UK Retirement Planning

Fulgent Genetics, Inc. Shareholders Are Encouraged to Reach

Legal & General and Standard Life investors loved Aviva's mixed results

Legal & General Shares Surge After CEO Rejects Sale Speculation (LGEN)

Legal & General shares slip as Jefferies cuts to underperform with 26% downside target

Fulgent Genetics, Inc. Q1 2026 Earnings Call Summary

Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Beats Revenue Estimates

Legal & General (LSE:LGEN) Cuts Earnings View in FTSE 100 Index

Legal & General faces earnings downgrades across every division as competition and solvency concerns mount

UBS warns Legal & General's 9% dividend yield comes with a catch

The Income Investor: Legal & General shares vs cash

Fulgent Genetics: A Major Market Misconception (NASDAQ:FLGT)

Legal & General: Short-Term Earnings Miss, Long-Term Growth And Yield Story Intact

A Look At Legal & General Group’s (LSE:LGEN) Valuation After Recent Share Price Weakness

Legal & General Group H2 Earnings Call Highlights